
    
      After analysis demonstrated the improved prognostic value of identifying both hypercellular
      tumor (TVHCV) based on high b-value diffusion-weighted magnetic resonance imaging (DW-MRI)
      and hyperperfused tumor (TVCBV) based on dynamic contrast-enhanced MRI (DCE-MRI), the study
      was amended and later-enrolled patients boosted to both TVHCV and TVCBV.
    
  